Climate ChangeNCT07541885
Artificial Intelligence Education and Climate Awareness in Pregnancy
A study testing Intervention 1 in people with Climate Change and Maternal Health, run by Derya Kaya Senol.
Trial summary
This quasi-experimental pretest-posttest study aimed to evaluate the effect of artificial intelligence-assisted climate change education on pregnant women's climate change concerns and awareness. Read more about this study
- Who is it for?
- Ages 18 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Climate Change, Maternal Health, Fetal Health
- What is being tested?
- Intervention 1
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 82 participants
- Where
- No sites listed yet
- Study dates
- 1 Apr 2026to 1 Jul 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Aged 18 years or older
- In the second or third trimester of pregnancy
- Able to speak Turkish
- Willing to participate and provide informed consent
Who cannot join
- Presence of a high-risk pregnancy
- Multiple pregnancy (e.g., twins or higher-order gestation)
- Failure to complete either the pre-test or the post-test questionnaire(s)
About this study
Official title: The Effect of Artificial Intelligence-Assisted Climate Change Education on Pregnant Women's Climate Change Concerns and Awareness: A Quasi-Experimental Pretest-Posttest Study
This quasi-experimental pretest-posttest study aimed to evaluate the effect of artificial intelligence-assisted climate change education on pregnant women's climate change concerns and awareness. The study will be conducted with pregnant women attending a pregnancy school, and participants will be assigned to intervention and control groups. The intervention group will receive AI-supported climate change education in addition to routine training, while the control group will receive only routine education. Data will be collected using the Climate Change Anxiety Scale and the Maternal-Fetal Health Awareness of Climate Change Scale. The findings are expected to contribute to improving pregnant women's awareness and reducing concerns related to climate change through innovative educational approaches.
- Being tested
- Intervention 1, Control
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intervention 1Other
Participants in the intervention group will receive routine education provided in the Pregnancy School program in addition to an artificial intelligence-assisted educational video about climate change and its effects on maternal and fetal health. The education will be delivered during scheduled sessions, and participants will complete pretest and posttest assessments measuring climate change concerns and awareness.
ControlOther
Participants in the control group will receive only the routine education provided in the Pregnancy School program without any additional artificial intelligence-assisted educational intervention. Pretest and posttest assessments will also be conducted in this group to evaluate climate change concerns and awareness.
| Study group | Role | What they receive |
|---|---|---|
| Study | Experimental | artificial intelligence-assisted educational video Receives: Other: Intervention 1; Other: Control |
| Control | No intervention | Routine education provided |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Climate Change Awareness Score (Pretest-Posttest)
In this study, the Awareness Scale of the Effects of Climate Change on Maternal and Fetal Health in Pregnant Women (ASCC-MFH-PW) was used to assess pregnant women's awareness of the effects of climate change on maternal and fetal health. The scale consists of 21 items and three subdimensions ("General," "Maternal," and "Fetal"). Items are rated on a 5-point Likert scale ranging from "1 = Strongly disagree" to "5 = Strongly agree," and there are no reverse-coded items. The total score ranges from 21 to 105, with higher scores indicating greater awareness of the effects of climate change on maternal and fetal health among pregnant women. In the original validation study, the overall Cronbach's alpha coefficient ranged between 0.943 and 0.946, while the subscale coefficients ranged from 0.837 to 0.924 (Kısrık \& Avcıbay Vurgeç, 2022).
Measured: From baseline (pretest conducted before the Pregnancy School session) to immediately after the session (posttest).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Apr 2026
- Study start1 Apr 2026 (estimated)
- Primary completion1 Jul 2026 (estimated)
- Study completion1 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Climate ChangeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 82 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Derya Kaya Senol
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Derya Kaya Senol, Osmaniye Korkut Ata University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07541885
- Sponsor's protocol ID
- OSMANİYE KORKUT ATA ÜNİVERSİTE
- Status last verified
- Apr 2026
- First submitted
- 14 Mar 2026
- Last updated
- 21 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No